RAPID – Photoaffinity-Based High-Throughput Ligand Discovery in Cells
- Pivoting away from mass spec in favor of building a high-throughput chemotherapeutics hit identification platform
- Discovery of first-in-class inhibitors of a genetically validated target for the treatment of PKU Discovery of the first inhibitors for transcription factor IRF3
- Evolving the platform to work with other covalent warheads